Cargando…
Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis
Psoriasis is a common, chronic and relapsing inflammatory skin disease. It affects approximately 2% of the western population and has no cure. Combination therapy for psoriasis often proves more efficacious and better tolerated than monotherapy with a single drug. Combination therapy could be admini...
Autores principales: | Lau, Wing Man, Heard, Charles M., White, Alex W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834954/ https://www.ncbi.nlm.nih.gov/pubmed/24300448 http://dx.doi.org/10.3390/pharmaceutics5020232 |
Ejemplares similares
-
TCM Treatment and Drug Co-Occurrence Analysis of Psoriasis
por: Lin, Li, et al.
Publicado: (2022) -
Design, synthesis and in vitro evaluation of novel bivalent S-adenosylmethionine analogues
por: Joce, Catherine, et al.
Publicado: (2012) -
Retracted: TCM Treatment and Drug Co-Occurrence Analysis of Psoriasis
por: Intelligence and Neuroscience, Computational
Publicado: (2023) -
Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab
por: Garcia-Valladares, Ignacio, et al.
Publicado: (2011) -
Design and synthesis of hybrid compounds as novel drugs and medicines
por: Alkhzem, Abdulaziz H., et al.
Publicado: (2022)